vatalanib has been researched along with cyclosporine in 2 studies
Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) | Studies (cyclosporine) | Trials (cyclosporine) | Recent Studies (post-2010) (cyclosporine) |
---|---|---|---|---|---|
276 | 42 | 98 | 377 | 2 | 170 |
276 | 42 | 98 | 30,547 | 3,802 | 6,558 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Kallio, EA; Koskinen, PK; Lemström, KB; Malmström, NK; Nykänen, AI; Paavonen, T; Räisänen-Sokolowski, AK; Rintala, JM | 1 |
2 other study(ies) available for vatalanib and cyclosporine
Article | Year |
---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vascular endothelial growth factor in chronic rat allograft nephropathy.
Topics: Animals; Cyclosporine; Disease Models, Animal; Graft Rejection; Kidney; Kidney Diseases; Kidney Transplantation; Male; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; Signal Transduction; Transplantation, Homologous; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2008 |